Advertisement

Saccharomyces cerevisiae inhibits growth and metastasis and stimulates apoptosis in HT-29 colorectal cancer cell line

  • Roshanak Sambrani
  • Jalal Abdolalizadeh
  • Leila Kohan
  • Behboud Jafari
Original Article
  • 28 Downloads

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Accumulating evidence has suggested that probiotics affect cellular pathways and specific genes involved in slow growth. Probiotics reduce the impact or stop the growth of cancer cells and tumors in animal models and human cell lines. The aim of this study was to investigate the effect of Saccharomyces cerevisiae (S. cerevisiae) on cell growth, metastasis, and apoptosis of the HT-29 colon cancer cell line. The HT-29 cells and S. cerevisiae were co-cultured in order to study the effects of S. cerevisiae on cell apoptosis, growth, and metastasis using 4,6-diamidino-2-phenylindole (DAPI) staining, 3-(4,5-dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and scratch wound-healing assay, respectively. Real-time PCR was applied to evaluate the expression levels of Akt/PTEN, MAPK, and NF-ĸB genes. The supernatant obtained from S. cerevisiae in HT-29 cell line increased the expression of PTEN and Caspas3 genes in the first 24 h while the Bclxl and RelA genes showed decreased expression. By using MTT method after 48 h of treatment HT-29 cells with supernatant of S. cerevisiae, about 75% of the cells showed stopped growing. Therefore, it could be concluded that S. cerevisiae inhibits the growth of the HT-29 cells by inducing apoptosis and reducing metastasis.

Keywords

Apoptosis HT-29 Probiotics Saccharomyces cerevisiae 

Notes

Acknowledgements

This work was supported by Tabriz University of Medical Sciences and Islamic Azad University, Marvdasht.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

This article does not need any informed consent.

References

  1. Baricault L, Denariaz G, Houri J-J, Bouley C, Sapin C, Trugnan G (1995) Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16(2):245–252CrossRefGoogle Scholar
  2. Benchekroun MT, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H et al (2010) Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res 3(7):800–809CrossRefGoogle Scholar
  3. Bernardes NSR, Chakrabarty AM, Fialho AM (2010) Microbial-based therapy of cancer current progress and future prospects. Bioengineered Bugs 1(3):178–190CrossRefGoogle Scholar
  4. Bray M, Carpenter A. Assay guidance manual. Eli Lilly & Company and the National Center for advancing translational Sciences 2013Google Scholar
  5. Chan J, Cheung J, Luk S, Wu Y, Pang S, Fung K (2004) Anti-cancer and pro-apoptotic effects of an herbal medicine and Saccharomyces cerevisiae product (CKBM) on human hepatocellular carcinoma HepG2 cells in vitro and in vivo. Immunopharmacol Immunotoxicol 26(4):597–609CrossRefGoogle Scholar
  6. Chen X, Fruehauf J, Goldsmith JD, Xu H, Katchar KK, Koon HW et al (2009) Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apcmin mice. Gastroenterology 137(3):914–923CrossRefGoogle Scholar
  7. Chen Z-Y, Hsieh Y-M, Huang C-C, Tsai C-C (2017) Inhibitory effects of probiotic Lactobacillus on the growth of human colonic carcinoma cell line HT-29. Molecules. 22(1):107CrossRefGoogle Scholar
  8. Cohen E, Ophir I, Shaul YB (1999) Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci 112(16):2657–2666PubMedGoogle Scholar
  9. Commane D, Hughes R, Shortt C, Rowland I (2005) The potential mechanisms involved in the anticarcinogenic action of probiotics. Mutat Res 591(1):276–289CrossRefGoogle Scholar
  10. Cortes J (2004) Natural history and staging of chronic myelogenous leukemia. Hematol Oncol Clin North Am 18(3):569–584CrossRefGoogle Scholar
  11. Daniluk U (2012) Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment. J Clin Exp Oncol 1:2CrossRefGoogle Scholar
  12. Demir G, Klein H, Mandel-Molinas N, Tuzuner N (2007) Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol 7(1):113–116CrossRefGoogle Scholar
  13. dos Reis SA, da Conceição LL, Siqueira NP, Rosa DD, da Silva LL, Maria do Carmo GP (2017) Review of the mechanisms of probiotic actions in the prevention of colorectal cancer. Nutr Res 37:1–19CrossRefGoogle Scholar
  14. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516CrossRefGoogle Scholar
  15. Feldmann H (2011) Yeast: molecular and cell biology. John Wiley & Sons, HobokenGoogle Scholar
  16. Fleige S (2006) Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27(2):126–139CrossRefGoogle Scholar
  17. Foo N-P, Ou Yang H, Chiu H-H, Chan H-Y, Liao C-C, Yu C-K, Wang YJ (2011) Probiotics prevent the development of 1, 2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem 59(24):13337–13345CrossRefGoogle Scholar
  18. Fortin O, Aguilar-Uscanga B, Vu KD, Salmieri S, Lacroix M (2018) Cancer chemopreventive, antiproliferative, and superoxide anion scavenging properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii cell wall components. Nutr Cancer 70(1):83–96CrossRefGoogle Scholar
  19. Gaikwad SM, Thakur B, Sakpal A, Singh RK, Ray P (2015) Differential activation of NF-kappaB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. Int J Biochem Cell Biol 61:90–102CrossRefGoogle Scholar
  20. GHONEUM M (2004) GOLLAPUDI S. Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the baker’s yeast, in vitro. Anticancer Res 24(3A):1455–1464PubMedGoogle Scholar
  21. Ghoneum M, Hamilton J, Brown J, Gollapudi S (2005) Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker’s yeast, in vitro. Anticancer Res 25(2A):981–989PubMedGoogle Scholar
  22. Ghoneum M, El-Din NKB, Noaman E, Tolentino L (2008) Saccharomyces cerevisiae, the baker’s yeast, suppresses the growth of Ehrlich carcinoma-bearing mice. Cancer Immunol Immunother 57(4):581–592CrossRefGoogle Scholar
  23. Haier J, Nicolson GL (2002) PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 21(9):1450–1460CrossRefGoogle Scholar
  24. Jabber AJ, Mahdi N, Yaseen N (2011) The effect of beta glucan extract of Saccharomyces cerevieses on cancer cell growth in vitro. Iraq J Cancer Med Genet 4:53–58Google Scholar
  25. Jacobson J (2015) Yeasts as probiotics: established in animals, but what about man. Probiotics and Prebiotics: Current Research and Future Trends Caister Academic Press, Norfolk, UK, pp 115–134Google Scholar
  26. Jänicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273(16):9357–9360CrossRefGoogle Scholar
  27. Javmen A, Nemeikaite-Ceniene A, Grigiskis S, Jonauskiene I, Rudenkov M, Kacianauskas D et al (2015) S. cerevisiae β-glucan reduced viability of mouse hepatoma cells in vitro. Turk J Biol 39(4):562–566CrossRefGoogle Scholar
  28. Kim WH, Yeo M, Kim MS, Chun SB, Shin EC, Park JH, Park IS (2000) Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Color Dis 15(2):105–111CrossRefGoogle Scholar
  29. Kim JY, Woo HJ, Kim Y-S, Kim KH, Lee HJ (2003) Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line. Nutr Cancer 46(2):197–201CrossRefGoogle Scholar
  30. Lee SK, Kim HJ, Chi SG, Kim YW, Chae MJ, Jung JH et al (2005a) Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-γ through suppression of Nf-kb in Ht-29 cell. J Gastroenterol Hepatol 20:A123–A1A4Google Scholar
  31. Lee SK, Kim HJ, Chi SG, Jang JY, Nam KD, Kim NH et al (2005b) Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi 45(5):328–334Google Scholar
  32. Liang C-C, Park AY, Guan J-L (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols 2(2):329–333CrossRefGoogle Scholar
  33. Liu G, Du P, Zhang Z (2015) Myeloid differentiation factor 88 promotes cisplatin chemoresistance in ovarian cancer. Cell Biochem Biophys 71(2):963–969CrossRefGoogle Scholar
  34. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25(4):402–408CrossRefGoogle Scholar
  35. Madempudi RS, Kalle AM (2017) Antiproliferative effects of Bacillus coagulans Unique IS2 in colon cancer cells. Nutr Cancer 69(7):1062–1068CrossRefGoogle Scholar
  36. Maria Muccioli FB (2014) Toll- like receptors in ovarian cancer as targets for immunotherapies. Front Immunol 5:1–5Google Scholar
  37. Nozari S, Mohammadzadeh M, Faridvand Y, Tockmechi A, Movassaghpour A, Abdolalizadeh JJAoIM (2016) The study of extracellular protein fractions of probiotic candidate bacteria on cancerous cell line Arch Iran Med 19(11):779–785Google Scholar
  38. Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351(1–2):41–58CrossRefGoogle Scholar
  39. Oliveira RJ, Matuo R, Da Silva AF, Matiazi HJ, Mantovani MS, LRJTiv R (2007a) Protective effect of β-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO. Cells 21(1):41–52Google Scholar
  40. Oliveira RJ, Matuo R, Da Silva AF, Matiazi HJ, Mantovani MS, Ribeiro LR (2007b) Protective effect of β-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO cells. Toxicol Vitro 21(1):41–52CrossRefGoogle Scholar
  41. Organization WH, Unit WHOMoSA (2014) Global status report on alcohol and health, 2014. World Health Organization, GenevaGoogle Scholar
  42. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ (2006) Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 4(2):130–142CrossRefGoogle Scholar
  43. Rahbar Saadat YSN, Zununi Vahed S, Barzegari A, Barar J (2015) An update to DNA ladder assay for apoptosis detection. BioImpacts. 5(1):25–28CrossRefGoogle Scholar
  44. Ravi Subbiah M, Abplanalp W (2003) Ergosterol (major sterol of baker’s and brewer’s yeast extracts) inhibits the growth of human breast cancer cells in vitro and the potential role of its oxidation products. Int J Vitam Nutr Res 73(1):19–23CrossRefGoogle Scholar
  45. Saber A, Alipour B, Faghfoori Z, Yari Khosroushahi A (2017) Cellular and molecular effects of yeast probiotics on cancer. Crit Rev Microbiol 43(1):96–115CrossRefGoogle Scholar
  46. Sabnis R. n.d. 4, 6-Diamidino-2-phenylindole dihydrochloride (DAPI). Handbook of Fluorescent Dyes and Probes.145–7.Google Scholar
  47. Saito Y, Swanson X, Mhashilkar A, Oida Y, Schrock R, Branch C et al (2003) Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo. Gene Ther 10(23):1961–1969CrossRefGoogle Scholar
  48. Sato S, Itamochi H (2015) Ovarian cancer and drug resistance. Current Obstetrics and Gynecology Reports 4(1):18–25CrossRefGoogle Scholar
  49. Sepideh Zununi Vahed AB, Saadat YR, Mohammadi S, Samadi N (2016) A microRNA isolation method from clinical samples. BioImpacts 6(1):25–31CrossRefGoogle Scholar
  50. Sinicrope FA, Cleary KR, Stephens LC, Lee JJ, Levin B (1995) Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55(2):237–241PubMedGoogle Scholar
  51. Ting Shuang MW, Zhou Y, Shi C (2016) Over-expression of nuclear NF-κB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer. Exp Mol Pathol 100:139–144CrossRefGoogle Scholar
  52. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V, Aindelis G, Tompoulidou E, Lamprianidou EE et al (2016) Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PloS one. 11(2):e0147960CrossRefGoogle Scholar
  53. Vahed SZ, Barzegari A, Saadat YR, Goreyshi A, Omidi Y (2017) Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways. Biomed Pharmacother 94:1094–1100CrossRefGoogle Scholar
  54. Van der Aa Kühle A, Skovgaard K, Jespersen L (2005) In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. International Journal of Food Microbiology 101(1):29–39CrossRefGoogle Scholar
  55. Vasudevan KM, Gurumurthy S, Rangnekar VM (2004) Suppression of PTEN expression by NF-κB prevents apoptosis. Mol Cell Biol 24(3):1007–1021CrossRefGoogle Scholar
  56. Walker L, Aldhous M, Drummond H, Smith B, Nimmo E, Arnott I et al (2004) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 135(3):490–496CrossRefGoogle Scholar
  57. Westwater C, Balish E, Schofield DA (2005) Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell 4(10):1654–1661CrossRefGoogle Scholar
  58. Wright K, Kolios G, Westwick J, Ward SG (1999) Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem 274(24):17193–17201CrossRefGoogle Scholar
  59. Yakovlev AG, Ota K, Wang G, Movsesyan V, Bao W-L, Yoshihara K, Faden AI (2001) Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 21(19):7439–7446CrossRefGoogle Scholar
  60. Yang S-A, Paek S-H, Kozukue N, Lee K-R, Kim J-A (2006) α-Chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1/2 phosphorylation. Food Chem Toxicol 44(6):839–846CrossRefGoogle Scholar
  61. Yoon TJ, Kim TJ, Lee H, Shin KS, Yun YP, Moon WK et al (2008) Anti-tumor metastatic activity of β-glucan purified from mutated Saccharomyces cerevisiae. Int Immunopharmacol 8(1):36–42CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Genetic, Fars Science and Research BranchIslamic Azad UniversityMarvdashtIran
  2. 2.Department of Genetic Branch MarvdashtIslamic Azad UniversityMarvdashtIran
  3. 3.Drug Applied Research CenterTabriz University of Medical SciencesTabrizIran
  4. 4.Department of Biology, Arsanjan BranchIslamic Azad UniversityArsanjanIran
  5. 5.Department of Microbiology Ahar BranchIslamic Azad UniversityAharIran

Personalised recommendations